$KHRNF News

Last published 3y ago

3y agoKHRNFKhiron begins dispensation of insurance-covered prescriptions in ColombiaPR NewswireFollowing the Government of Colombia's decision on insurance coverage for medical cannabis, Khiron has begun dispensing medical cannabis to its patient base under the new mandate.TORONTO, Jan. 19, 2023 /CNW/ - Khiron
3y agoKHRNFNHS reimburses the cost of cannabis treatment to the first Zerenia™ Clinics UK patientPR NewswireZerenia™ Clinics UK, wholly owned by Khiron, succeeds at having the NHS reimbursing both the cost of cannabis-based treatment and clinic fees to its first patientKhiron trains doctors and nurses at an NHS- funded
3y agoKHRNFKhiron wins first medical cannabis contract with Colombia's largest public insurance companyPR NewswireOn December 27, 2022, Zerenia (Khiron´s wholly owned medical cannabis clinic network) signed a contract with CAPITAL SALUD EPS, Colombia´s largest public insurance company, under which Zerenia will provide medical
3y agoKHRNFGovernment of Colombia Declares Mandatory Insurance Coverage for Medical Cannabis ProductsPR NewswireOn December 30, 2022, the Ministry of Health of Colombia reaffirmed the inclusion of plant-based medical cannabis products, i.e., Khiron products, in the mandatory insurance coverage systemStarting January 1st, 2023,
3y agoKHRNFKhiron Life Sciences Reports Third Quarter 2022 Financial ResultsPR NewswireIn Europe, revenues increased by 141% year-over-year, driven by revenues in the United Kingdom, where the Corporation is now increasing its existing product portfolio, and the specialized cannabis clinic Zerenia™
3y agoKHRNFKhiron to Host Third Quarter 2022 Conference Call on November 30, 2022PR NewswireTORONTO, Nov. 18, 2022 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV:KHRN) (OTCQX:KHRNF) (Frankfurt: A2JMXC), the global leader in medical cannabis throughout Latin America and
3y agoKHRNFKhiron begins sales in Switzerland and expands its medical cannabis portfolio in Germany and the United KingdomPR NewswireThrough its newly acquired EU-GMP distribution hub in Germany, Khiron expands its product portfolio and geographic reach within Europe to Germany, UK, and Switzerland. Switzerland: Khiron enters the Swiss medical
4y agoKHRNFKhiron Life Sciences Awarded Best Latin American Cannabis Company at Benzinga Cannabis Capital ConferencePR NewswireTORONTO, Sept. 13, 2022 /PRNewswire/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV:KHRN) (OTCQX:KHRNF) (Frankfurt: A2JMZC), a global leader in medical cannabis throughout Europe and Latin America, today announced that received the Best
4y agoKHRNFKhiron, the Global Leader in Medical Cannabis Launches New Cannabis Products in Europe including Stellar Genetics from CaliforniaPR NewswireNew products to be distributed through Khiron's new wholly-owned subsidiary Pharmadrug Production GmbH Khiron introduces new THC-dominant full-spectrum extract KHIRIOX 25/1, and non-irradiated flower varieties KHIRON Gelato 19/1 and KHIRON Caramel 5/7
4y agoKHRNFKhiron Life Sciences Reports Second Quarter 2022 Financial ResultsPR NewswireReports revenues of $9.1 million in the first half of 2022, up 62% year-over-year, reflecting continued medical cannabis momentum in target markets Recorded its lowest ever Adjusted EBITDA loss in Q2 2022 at ($2.3) million, down 30% quarter-over-quarte
4y agoKHRNFKhiron to Host Second Quarter 2022 Conference Call on August 29, 2022PR NewswireTORONTO, Aug. 22, 2022 /PRNewswire/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV:KHRN)(OTCQX:KHRNF)(Frankfurt: A2JMXC), the global leader in medical cannabis throughout Latin America and Europe, today announces that it will host a Confe
4y agoKHRNFMedical Cannabis Leader Khiron Opens Brazil's First Zerenia™ ClinicPR NewswireContinued Global Growth of Khiron's Proven ZereniaTM Clinic ModelFocused on Patients, Physician Education and Innovation New clinic is in the district of Ipanema in Rio de Janeiro, a city with more than 12 million people Expansion into Brazil follows
4y agoKHRNFKhiron Appoints Helen Bellwood (ACA) as Interim CFOPR NewswireTORONTO, July 18, 2022 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV:KHRN) (OTCQX:KHRNF) (Frankfurt: A2JMZC), a global leader in medical cannabis throughout Latin America and Europe, today announced that Helen Bellwood (ACA) will b
4y agoKHRNFMedical Cannabis Leader Khiron Continues Global Expansion into SpainPR NewswireKhiron's Medical Clinics and Distribution Growth Throughout Europe Follows Success in Latin American Marketplace Since establishing a Spanish subsidiary in 2019, Khiron's scientific and medical team is recognized as cannabinoid experts in Spain Khiro
4y agoKHRNFMedical Cannabis Innovator Khiron Continues Global Expansion as Industry Leader Throughout Europe and Latin AmericaPR NewswireKhiron Serves Record Number of Patients With Khiron Products Globally in Its Medical Treatment Clinics TORONTO, June 28, 2022 /PRNewswire/ - Khiron Life Sciences Corp. (TSXV:KHRN) (OTCQX:KHRNF) (Frankfurt: A2JMZC) the global medical cannabis leader, co
4y agoKHRNFKhiron Announces Results of 2022 Annual General and Special MeetingPR NewswireTORONTO, June 23, 2022 /PRNewswire/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV:KHRN) (OTCQX:KHRNF) (Frankfurt: A2JMZC), a global leader in medical cannabis throughout Latin America and Europe, announces the results of its 2022 Annual
4y agoKHRNFKhiron Life Sciences Reports First Quarter 2022 Financial Results with Record Revenue in Medical CannabisPR NewswireThe Corporation recorded revenues of $4.6 million in Q1 2022, a 65% increase from Q1 2021, and a 28% increase from Q4 2021 Record revenue in medical cannabis of over $2.6 million in Q1 2022, a 470% increase from the prior year and 32% increase from Q4
4y agoKHRNFKhiron to Host First Quarter 2022 Conference Call on May 31, 2022PR NewswireTORONTO, May 25, 2022 /PRNewswire/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV:KHRN) (OTCQX:KHRNF) (Frankfurt: A2JMXC), the global medical cannabis leader expanding throughout Latin America and Europe, today announces that it will hos
4y agoKHRNFKhiron Life Sciences Reports 2021 Fiscal Year End ResultsPR Newswire2021 total revenue increased over 60% YoY to $12.8 million compared to the previous year Corporation's medical cannabis sales in 2021 increased to $4.6 million, representing 36% of total revenue The Corporation forecasts Q1 2022 sales revenue of ~ $4.
4y agoKHRNFKhiron to Host YE and Fourth Quarter 2021 Conference Call on May 2, 2022PR NewswireTORONTO, April 27, 2022 /PRNewswire/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV:KHRN)(OTCQX:KHRNF)(Frankfurt: A2JMZC), the global medical cannabis leader expanding throughout Latin America and Europe, today announces that it will host
4y agoKHRNFGlobal Medical Cannabis Leader Khiron Opens New Zerenia™ Clinic and Retail Pharmacy in ColombiaPR NewswireContinues market leadership in Colombia, Latin America's only country with universal health coverage for medical cannabis Market leader in the Colombian medical cannabis market, with Q1 2022 volume sales exceeding 21,400 units, up 280% YoY and more th
4y agoKHRNFLEADING GLOBAL MEDICAL CANNABIS COMPANY KHIRON PUBLISHES CLINICAL STUDY ON THE EFFECTIVENESS OF ITS PRODUCTS AT CONTROLLING CHRONIC PAINPR NewswireData Substantiates Company's Position as a Global Leader In Health Care Solutions Key findings in the study include: 9 out of 10 patients reported some degree of improvement of their chronic pain. 7 out of 10 reported an improvement larger than 50%
4y agoKHRNFMedical Cannabis Innovator Khiron Continues to Disrupt Global Marketplace Signing Partnership with Teleton in MexicoPR NewswireTeleton has 24 Medical Centers (22 rehabilitation centers, 1 autism center and 1 Children's Hospital for Cancer) located across the country, and around 600,000 patients with disability, cancer and autism conditions The partnership includes: Establi
4y agoKHRNFKhiron Life Sciences to Present at Upcoming March Investor ConferencesPR NewswireTORONTO, March 7, 2022 /PRNewswire/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV:KHRN)(OTCQX:KHRNF)(Frankfurt: A2JMZC), a medical cannabis leader with core operations in Latin America and Europe, is scheduled to participate in the follo
4y agoKHRNF OTCMKhiron Life Sciences Corp to Webcast Live at VirtualInvestorConferences.com March 10thGlobeNewswireTORONTO, March 07, 2022 (GLOBE NEWSWIRE) -- Khiron Life Sciences Corp. ("Khiron" or the "Company") (OTCQX:KHRNF) (TSXV:KHRN) (Frankfurt:A2JMZC), a medical cannabis leader with core operations in Latin America and Europe, today announced that Alvaro To
4y agoKHRNFKhiron Adds Another Clinic Location in PeruPR NewswireKhiron partners with specialized pain clinic, Clínica del Dolor Lima ("CDL") to provide medical cannabis treatment access to its over 10,000 chronic pain patient population TORONTO, Feb. 17, 2022 /PRNewswire/ - Khiron Life Sciences Corp. ("Khiron" or
4y agoKHRNFKhiron Opens New Medical Cannabis Clinic in ColombiaPR NewswireNew 4,000 sq.ft. facility becomes 4th medical cannabis clinic in Bogota Khiron opens its 4th Zerenia-branded medical cannabis clinic in the city of Bogota The new clinic, with a capacity of up to 40,000 consults per year could add 20% to the existin
4y agoKHRNFMandatory Insurance Coverage for Medical Cannabis Now Expands to More than 50 million ColombiansPR NewswireStarting January 1st, 2022, every insurance provider in Colombia, is now mandated to cover the costs of high and low THC medical cannabis prescriptions Significantly improves the current insurance coverage process, simplifying the procedure and reduci
4y agoKHRNFKhiron to Participate in the Lytham Partners Winter 2021 Investor ConferencePR NewswireTORONTO, Dec. 9, 2021 /PRNewswire/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV:KHRN) (OTCQX:KHRNF) (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe, announced today its CEO,
4y agoKHRNFKhiron Announces Grants of Options and Restricted Share UnitsPR NewswireTORONTO, Nov. 23, 2021 /PRNewswire/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV:KHRN) (OTCQX:KHRNF) (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe, announces the award of
4y agoKHRNFKhiron Reports Q3 Results - Revenue Increased 83% YoY, 26% QoQPR NewswireQ3 2021 revenue increased 83% YoY to $3.5 million compared to the previous year Gross profit before changes in FV in Q3 2021 increased 62% sequentially to $1.7 million Medical cannabis revenues increased 46% sequentially to $1.2 million Continued
4y agoKHRNFKhiron to Host Third Quarter 2021 Conference Call on November 22, 2021PR NewswireTORONTO, Nov. 16, 2021 /PRNewswire/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV:KHRN) (OTCQX:KHRNF)(Frankfurt: A2JMZC), a vertically integrated medical cannabis leader with core operations in Latin America and Europe, today announces t
5y agoKHRNFKhiron Life Sciences to Present at Upcoming November Investor ConferencesPR NewswireTORONTO, Nov. 8, 2021 /PRNewswire/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV:KHRN)(OTCQX:KHRNF)(Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe, is scheduled to participate
5y agoAAZZF ABIO ACOGF ACST+81Investor Summit Group Provides Update on Upcoming Q4 Virtual SummitGlobeNewswireNEW YORK, Nov. 05, 2021 (GLOBE NEWSWIRE) -- The Investor Summit Group, widely recognized for its reputation as the host of North America's largest independent investor conferences, will be hosting the upcoming Q4 Virtual Summit on November 16-17. The e
5y agoKHRNFKhiron Opens First clinic in Europe with Zerenia™ Clinics UKPR NewswireZerenia™ Clinics UK is a specialist medical cannabis clinic in London and another strategic approach by Khiron to improve access to medical cannabis for patients in the UK Hybrid clinic model: Zerenia™ Clinics UK is a digital clinic (www.zereniacl
5y agoKHRNFKhiron presents its first research study with 1,400 patientsPR Newswire12-month observational study results presented at the International Pain Conference in Colombia on September 25th, 2021 1st research study of its kind with a significant patient base for medical cannabis in LatAm 1,453 patients in 12-month period, s
5y agoKHRNFKhiron reports medical cannabis prescription growth in South America and EuropePR NewswireTORONTO, Oct. 4, 2021 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV:KHRN) (OTCQX:KHRNF)(Frankfurt: A2JMZC), a vertically integrated international cannabis leader with core operations in Latin America and Europe, is pleased to provi
5y agoKHRNFKhiron Receives Approval To Renew Its Normal Course Issuer BidPR NewswireTORONTO, Sept. 13, 2021 /PRNewswire/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV:KHRN), (OTCQB:KHRNF), (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America, is pleased to announce that, f
5y agoKHRNFKhiron Announces Intention to Renew its Normal Course Issuer BidPR NewswireTORONTO, Sept. 9, 2021 /PRNewswire/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV:KHRN), (OTCQX:KHRNF) , (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe, announces today its
5y agoKHRNFKhiron Registers its First Two Medical Cannabis Products in Peru, Available for Sale NationwidePR NewswireAlixen™ 30 and Alixen™ 100, CBD-rich products, become Khiron's first two registered medical cannabis products, following approval by the Peruvian sanitary agency, DIGEMID Shelf-ready Alixen™ 30 and Alixen™ 100, exported from Colombia, to be br
5y agoKHRNFKhiron Reports Q2 Results, 47% QoQ Increase in Medical Cannabis Revenues Driven by Colombia and GermanyPR NewswireQ2 2021 revenues of $2.8 million, up 68% YoY Medical cannabis revenues reach $825,500, up 47% sequentially, with sales in Colombia, Germany, UK, and Peru contributing to gross medical cannabis profit margin of 88% European medical cannabis sales gro
5y agoKHRNFKhiron to Host Second Quarter 2021 Conference Call on August 23, 2021PR NewswireTORONTO, Aug. 17, 2021 /PRNewswire/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV:KHRN) (OTCQX:KHRNF)(Frankfurt: A2JMZC), a vertically integrated medical cannabis leader with core operations in Latin America and Europe, today announces t
5y agoKHRNFKhiron Publishes Inaugural 2020 ESG Report, Demonstrating Commitment to Sustainability and Continued Market LeadershipPR NewswireTORONTO, Aug. 10, 2021 /PRNewswire/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV:KHRN) (OTCQX:KHRNF)(Frankfurt: A2JMZC), a vertically integrated medical cannabis leader with core operations in Latin America and Europe, is pleased to ann
5y agoKHRNFKhiron Welcomes Dr. Eduardo Faveret as Medical Director for BrazilPR NewswireIn 2013, Dr. Faveret became one of the first Brazilian physicians to prescribe medical cannabis, subsequently treating more than 3,000 patients with various conditions across the country As Medical Director for Zerenia™, Dr. Faveret will lead patien
5y agoKHRNFColombia Expands Distribution of Medical Cannabis to Pharmacies Nationwide and Opens Export Market for Dried Flower Medical CannabisPR NewswireOn July 23, 2021, the Colombian Government signed Decree 811 of 2021, expanding the regulatory framework for domestic and export medical cannabis markets in Colombia With the Decree, Colombia continues to serve as a regulatory leader and reference poi
5y agoKHRNFKhiron Announces Results of 2021 Annual General MeetingPR NewswireLytham Partners to Provide Investor Relations Services TORONTO, July 2, 2021 /PRNewswire/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV:KHRN)(OTCQX:KHRNF)(Frankfurt: A2JMZC), a vertically integrated medical cannabis leader with core
5y agoKHRNFKhiron successfully completes first medical cannabis sale in BrazilPR NewswireWith over 200 million people, Brazil is Latin America´s largest addressable medical cannabis market, with the potential to reach USD$1.4 billion in annual revenue (Source: New Frontier Data) In partnership with leading medical cannabis patient associ
5y agoKHRNFVicente Fox, Khiron Board Member and Former President of Mexico, Applauds Mexican Supreme Court's Advancement of Cannabis LawsPR NewswireMexico's Supreme Court has voted to decriminalize adult use cannabis, allowing adults to apply for permits to cultivate and consume their own cannabis Khiron reiterates plans to enter Mexican medical cannabis market in 2021 through previously announce
5y agoKHRNFKhiron Accelerates Entry into Mexico, Awarded High-THC Extract Export Quotas for Mexico by the Government of ColombiaPR NewswireWith a population close to 130 million people, Mexico is among the top 15 economies worldwide and second largest in Latin America. Approximately 11.7 million people have conditions treatable with medical cannabis (Source: IMS Quintiles) Leveraging its
5y agoKHRNFKhiron provides European management updatesPR NewswireTORONTO, June 14, 2021 /PRNewswire/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV:KHRN) (OTCQX:KHRNF) (Frankfurt: A2JMZC), a vertically integrated medical cannabis leader with core operations in Latin America and Europe, is pleased to an